ARTICLE | Company News
Celldex, CuraGen deal
October 5, 2009 7:00 AM UTC
Celldex completed its previously announced acquisition of fellow cancer company CuraGen for about $93.5 million in a stock (see BioCentury, June 1). ...
Celldex completed its previously announced acquisition of fellow cancer company CuraGen for about $93.5 million in a stock (see BioCentury, June 1). ...